{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:19:14Z","timestamp":1771823954179,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG2018\u201321339"],"award-info":[{"award-number":["IG2018\u201321339"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["MFGA2018\u201321505"],"award-info":[{"award-number":["MFGA2018\u201321505"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.lungcan.2022.10.003","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T04:16:17Z","timestamp":1666152977000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC"],"prefix":"10.1016","volume":"174","author":[{"given":"Fabio","family":"Salomone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Di Costanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Viscardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Viggiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Santaniello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Formisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3624-224X","authenticated-orcid":false,"given":"Alberto","family":"Servetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2022.10.003_b0005","first-page":"1121","article-title":"Clinical endpoints in oncology - a primer","volume":"11","author":"Delgado","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.lungcan.2022.10.003_b0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.critrevonc.2017.11.014","article-title":"Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical review","volume":"123","author":"Savina","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lungcan.2022.10.003_b0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/annonc\/mdv562","article-title":"Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents","volume":"27","author":"Saad","year":"2016","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2022.10.003_b0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00019053-200119020-00005","article-title":"Health-Related Quality of Life (HR-QOL) and Regulatory Issues: An Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval","volume":"19","author":"Apolone","year":"2001","journal-title":"PharmacoEconomics"},{"issue":"9","key":"10.1016\/j.lungcan.2022.10.003_b0025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","article-title":"The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline","volume":"33","author":"Di Maio","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2022.10.003_b0030","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/annonc\/mdv249","article-title":"A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)","volume":"26","author":"Cherny","year":"2015","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.lungcan.2022.10.003_b0035","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/annonc\/mdx310","article-title":"ESMO-Magnitude of Clinical Benefit Scale version 1.1","volume":"28","author":"Cherny","year":"2017","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.lungcan.2022.10.003_b0040","first-page":"3143","article-title":"Assessing quality of life in long-term cancer survivors: a review of available tools","volume":"21","author":"Muzzatti","year":"2013","journal-title":"Support. Care Cancer."},{"key":"10.1016\/j.lungcan.2022.10.003_b0045","first-page":"153","article-title":"Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review, Eur","volume":"5","author":"Ratti","year":"2022","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.lungcan.2022.10.003_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102321","article-title":"Quality-of-life methodology in hormone receptor\u2013positive advanced breast cancer: Current tools and perspectives for the future","volume":"102","author":"Cardoso","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lungcan.2022.10.003_b0055","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/annonc\/mdy449","article-title":"Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016","volume":"29","author":"Marandino","year":"2018","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.lungcan.2022.10.003_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103649","article-title":"Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review","volume":"172","author":"Servetto","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lungcan.2022.10.003_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00715","article-title":"Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review","volume":"9","author":"Van Der Weijst","year":"2019","journal-title":"Front. Oncol."},{"issue":"2010","key":"10.1016\/j.lungcan.2022.10.003_b0070","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ."},{"issue":"8","key":"10.1016\/j.lungcan.2022.10.003_b0075","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"for the CONSORT PRO Group, Reporting of Patient-Reported Outcomes in Randomized Trials","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.lungcan.2022.10.003_b0080","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/pon.5025","article-title":"Assessing the psychosocial needs of newly diagnosed patients with nonsmall cell lung cancer: Identifying factors associated with distress","volume":"28","author":"Leung","year":"2019","journal-title":"Psychooncology."},{"key":"10.1016\/j.lungcan.2022.10.003_b0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.lungcan.2012.06.007","article-title":"Issues surrounding clinical trial endpoints in solid malignancies with a focus on metastatic non-small cell lung cancer","volume":"77","author":"Garon","year":"2012","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2022.10.003_b0090","first-page":"15","article-title":"Health-related quality of life questionnaires in lung cancer trials: a systematic literature review., Health","volume":"3","author":"Damm","year":"2013","journal-title":"Econ. Rev."},{"key":"10.1016\/j.lungcan.2022.10.003_b0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/bmj.317.7161.771","article-title":"Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews","volume":"317","author":"Silvestri","year":"1998","journal-title":"BMJ."},{"key":"10.1016\/j.lungcan.2022.10.003_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lungcan.2019.10.022","article-title":"Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018","volume":"139","author":"Reale","year":"2020","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2022.10.003_b0105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamaoncol.2022.0864","article-title":"Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class","volume":"8","author":"Samuel","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2022.10.003_b0110","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/ijc.31957","article-title":"Association between progression-free survival and patients\u2019 quality of life in cancer clinical trials","volume":"144","author":"Hwang","year":"2019","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.lungcan.2022.10.003_b0115","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/jamainternmed.2018.4710","article-title":"Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology","volume":"178","author":"Kovic","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.lungcan.2022.10.003_b0120","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/cancers14040889","article-title":"Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years","volume":"14","author":"Falcone","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.lungcan.2022.10.003_b0125","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s11136-022-03119-w","article-title":"Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews","volume":"31","author":"Mercieca-Bebber","year":"2022","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.lungcan.2022.10.003_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103747","article-title":"Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic review","volume":"176","author":"Waisberg","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lungcan.2022.10.003_b0135","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2016-000100","article-title":"Esmo -, Magnitude of Clinical Benefit Scale vol 1.0 questions and answers","volume":"1","author":"Cherny","year":"2016","journal-title":"ESMO Open."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222006638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222006638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:01:15Z","timestamp":1759237275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222006638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":27,"alternative-id":["S0169500222006638"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.10.003","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}